Analysis: Positioning to Benefit within Uranium Energy, Bellicum Pharmaceuticals, Tutor Perini, Maiden, Hill-Rom, and BioDelivery Sciences International — Research Highlights Growth, Revenue, and Cons

Analysis: Positioning to Benefit within Uranium Energy, Bellicum Pharmaceuticals, Tutor Perini, Maiden, Hill-Rom, and BioDelivery Sciences International — Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, June 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Uranium Energy Corp. (NYSE:UEC), Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), Tutor Perini Corporation (NYSE:TPC), Maiden Holdings, Ltd. (NASDAQ:MHLD), Hill-Rom Holdings, Inc. (NYSE:HRC), and BioDelivery Sciences International, Inc. (NASDAQ:BDSI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

UEC DOWNLOAD: http://Fundamental-Markets.com/register/?so=UEC
BLCM DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BLCM
TPC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=TPC
MHLD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=MHLD
HRC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HRC
BDSI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BDSI

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Uranium Energy Corp. (NYSE:UEC), Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), Tutor Perini Corporation (NYSE:TPC), Maiden Holdings, Ltd. (NASDAQ:MHLD), Hill-Rom Holdings, Inc. (NYSE:HRC), and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 13th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Uranium Energy Corp. (UEC) REPORT OVERVIEW

Uranium Energy's Recent Financial Performance

Uranium Energy is expected to report earnings on October 12th, 2018. The report will be for the fiscal period ending July 31st, 2018. The estimated EPS forecast for the next fiscal year is -$0.08 and is expected to report on October 12th, 2018.

To read the full Uranium Energy Corp. (UEC) report, download it here: http://Fundamental-Markets.com/register/?so=UEC

-----------------------------------------

Bellicum Pharmaceuticals, Inc. (BLCM) REPORT OVERVIEW

Bellicum Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Bellicum Pharmaceuticals reported revenue of $0.15MM vs $0.13MM (up 20.31%) and basic earnings per share -$0.68 vs -$0.80. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Bellicum Pharmaceuticals reported revenue of $0.19MM vs $0.39MM (down 52.32%) and basic earnings per share -$2.89 vs -$2.57. Bellicum Pharmaceuticals is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.74. The estimated EPS forecast for the next fiscal year is -$2.50 and is expected to report on March 12th, 2019.

To read the full Bellicum Pharmaceuticals, Inc. (BLCM) report, download it here: http://Fundamental-Markets.com/register/?so=BLCM

-----------------------------------------

Tutor Perini Corporation (TPC) REPORT OVERVIEW

Tutor Perini's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Tutor Perini reported revenue of $1,028.16MM vs $1,117.36MM (down 7.98%) and basic earnings per share -$0.24 vs $0.28. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tutor Perini reported revenue of $4,757.21MM vs $4,973.08MM (down 4.34%) and basic earnings per share $2.99 vs $1.95 (up 53.33%). Tutor Perini is expected to report earnings on August 6th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.59. The estimated EPS forecast for the next fiscal year is $2.89 and is expected to report on February 26th, 2019.

To read the full Tutor Perini Corporation (TPC) report, download it here: http://Fundamental-Markets.com/register/?so=TPC

-----------------------------------------

Maiden Holdings, Ltd. (MHLD) REPORT OVERVIEW

Maiden's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Maiden reported revenue of $732.39MM vs $756.31MM (down 3.16%) and basic earnings per share $0.17 vs $0.24 (down 29.17%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Maiden reported revenue of $2,921.15MM vs $2,731.63MM (up 6.94%) and basic earnings per share -$2.32 vs $0.20. Maiden is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is $1.35 and is expected to report on February 27th, 2019.

To read the full Maiden Holdings, Ltd. (MHLD) report, download it here: http://Fundamental-Markets.com/register/?so=MHLD

-----------------------------------------

Hill-Rom Holdings, Inc. (HRC) REPORT OVERVIEW

Hill-Rom's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Hill-Rom reported revenue of $710.50MM vs $678.90MM (up 4.65%) and basic earnings per share $0.43 vs $0.52 (down 17.31%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Hill-Rom reported revenue of $2,743.70MM vs $2,655.20MM (up 3.33%) and basic earnings per share $2.04 vs $1.90 (up 7.37%). Hill-Rom is expected to report earnings on July 27th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.91. The estimated EPS forecast for the next fiscal year is $5.12 and is expected to report on November 2nd, 2018.

To read the full Hill-Rom Holdings, Inc. (HRC) report, download it here: http://Fundamental-Markets.com/register/?so=HRC

-----------------------------------------

BioDelivery Sciences International, Inc. (BDSI) REPORT OVERVIEW

BioDelivery Sciences International's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, BioDelivery Sciences International reported revenue of $11.28MM vs $29.48MM (down 61.73%) and basic earnings per share -$0.18 vs $0.89. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BioDelivery Sciences International reported revenue of $61.99MM vs $15.55MM (up 298.72%) and basic earnings per share $0.10 vs -$1.25. BioDelivery Sciences International is expected to report earnings on August 8th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.27. The estimated EPS forecast for the next fiscal year is -$0.37 and is expected to report on March 21st, 2019.

To read the full BioDelivery Sciences International, Inc. (BDSI) report, download it here: http://Fundamental-Markets.com/register/?so=BDSI

-----------------------------------------

ABOUT Fundamental Markets

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.